BusinessEditas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care ConferenceBy Nasdaq OMXMay 8, 2018, 12:02 PM UTC
BusinessEditas Medicine Announces First Quarter 2018 Results and UpdateBy Nasdaq OMXMay 3, 2018, 8:02 PM UTC
BusinessEditas Medicine to Present New Data Demonstrating Progress Towards Creating Genome Editing Medicines at the American Society of Gene & Cell Therapy Annual MeetingBy Nasdaq OMXApr 30, 2018, 5:30 PM UTC
BusinessEditas Medicine to Host Conference Call Discussing First Quarter 2018 Corporate Update and ResultsBy Nasdaq OMXApr 26, 2018, 8:01 PM UTC
BusinessEditas Medicine Names James C. Mullen as Chairman of the Board of DirectorsBy Nasdaq OMXMar 28, 2018, 1:01 PM UTC
BusinessEditas Medicine Announces Fourth Quarter and Full Year 2017 Results and UpdateBy Nasdaq OMXMar 6, 2018, 9:01 PM UTC
BusinessEditas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare DiseasesBy Nasdaq OMXFeb 28, 2018, 2:01 PM UTC
BusinessEditas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and ResultsBy Nasdaq OMXFeb 27, 2018, 9:01 PM UTC
